Risk Factors Influencing the Outcomes of Kidney Re-Transplantation

被引:5
作者
Schwarz, Anke [1 ]
Schaefer, Frank [1 ]
Framke, Theodor [2 ]
Linnenweber-Held, Silvia [1 ]
Richter, Nicolas [3 ]
Haller, Hermann [1 ]
机构
[1] Hannover Med Sch, Dept Nephrol & Hypertens, Hannover, Germany
[2] Hannover Med Sch, Inst Biostat, Hannover, Germany
[3] Hannover Med Sch, Dept Visceral Surg & Transplantat, Hannover, Germany
关键词
RABBIT ANTITHYMOCYTE GLOBULIN; HUMAN-LEUKOCYTE ANTIGEN; ORGAN-TRANSPLANTATION; UNITED-STATES; SURVIVAL; FAILURE; FRAILTY; ANTIBODIES; RECIPIENTS; INDUCTION;
D O I
10.12659/AOT.928922
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Our kidney transplant waitlist includes 20% re-transplantations (TX2). Knowing what to expect is a clinical obligation. Material/Methods: We compared graft and patient survival of all 162 TX2 patients, transplanted 2000 to 2009, with 162 patients after first transplantation (TX1) matched for age, sex, living/non-living donation, and transplantation date. Patient follow-up was 10 years. Results: TX2 graft and patient survivals were inferior to TX1 (p<0.001 and p=0.047). TX2 patients had a longer cumulative dialysis vintage, more human leucocyte antigen (HLA) mismatches, more panel-reactive HLA antibodies, more often received induction therapy with rabbit-antithymocyte globulin (rATG), and had a lower body mass index (all p<0.05). Death from infection and graft failure by rejection was more frequent after TX2 (both p<0.05) but not after TX1. Multivariable Cox regression analysis revealed that both cohorts had graft failure and death risk associated with infection and cardiovascular disease, and graft failure by humoral rejection. However, only TX2 patients had an additional risk of graft failure with early inferior graft function and of patient death with >_2 comorbidities. Moreover, Kaplan-Meier analysis showed that TX2 and not TX1 patients had a lower graft and patient survival associated with infection and with >_2 comorbidities (all p<0.05). Conclusions: Re-transplantation is associated with worse graft outcomes mainly because of immunologic and graft-quality reasons, although the high number of comorbidities and infection severities aside from cardiovascular disease drive mortality. The more frequent rATG induction of TX2 patients could promote infection by enhancing immunosuppression. By addressing comorbidities, outcomes could possibly be improved.
引用
收藏
页数:23
相关论文
共 47 条
  • [1] The Association between Body Mass Index and Mortality in Incident Dialysis Patients
    Badve, Sunil V.
    Paul, Sanjoy K.
    Klein, Kerenaftali
    Clayton, Philip A.
    Hawley, Carmel M.
    Brown, Fiona G.
    Boudville, Neil
    Polkinghorne, Kevan R.
    McDonald, Stephen P.
    Johnson, David W.
    [J]. PLOS ONE, 2014, 9 (12):
  • [2] Long-term outcome of third, fourth and fifth kidney transplantation: technical aspects and immunological challenges
    Benkoe, Tamas
    Halfmann, Patrizia
    Gaeckler, Anja
    Raduenz, Sonia
    Treckmann, Jurgen W.
    Kaiser, Gernot M.
    Hoyer, Dieter P.
    [J]. CLINICAL KIDNEY JOURNAL, 2019, 12 (06) : 895 - 900
  • [3] Rabbit antithymocyte globulin versus basiliximab in renal transplantation
    Brennan, Daniel C.
    Daller, John A.
    Lake, Kathleen D.
    Cibrik, Diane
    Del Castillo, Domingo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (19) : 1967 - 1977
  • [4] DETECTION OF PANEL-REACTIVE ANTI-HLA CLASS-I ANTIBODIES BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY OR LYMPHOCYTOTOXICITY - RESULTS OF A BLINDED, CONTROLLED MULTICENTER STUDY
    BUELOW, R
    MERCIER, I
    GLANVILLE, L
    REGAN, J
    ELLINGSON, L
    JANDA, G
    CLAAS, F
    COLOMBE, B
    GELDER, F
    GROSSEWILDE, H
    OROSZ, C
    WESTHOFF, U
    VOEGELER, U
    MONTEIRO, F
    POULETTY, P
    [J]. HUMAN IMMUNOLOGY, 1995, 44 (01) : 1 - 11
  • [5] Access to Kidney Transplantation after a Failed First Kidney Transplant and Associations with Patient and Allograft Survival: An Analysis of National Data to Inform Allocation Policy
    Clark, Stephanie
    Kadatz, Matthew
    Gill, Jagbir
    Gill, John S.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (08): : 1228 - 1237
  • [6] Ten-year survival of second kidney transplants: Impact of immunologic factors and renal function at 12 months
    Coupel, S
    Giral-Classe, M
    Karam, G
    Morcet, JF
    Dantal, J
    Cantarovich, D
    Blancho, G
    Bignon, JD
    Daguin, P
    Soulillou, JP
    Hourmant, M
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (02) : 674 - 680
  • [7] Frailty in older adults: Evidence for a phenotype
    Fried, LP
    Tangen, CM
    Walston, J
    Newman, AB
    Hirsch, C
    Gottdiener, J
    Seeman, T
    Tracy, R
    Kop, WJ
    Burke, G
    McBurnie, MA
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2001, 56 (03): : M146 - M156
  • [8] GAROVOY MR, 1983, TRANSPLANT P, V15, P1939
  • [9] Duration of end-stage renal disease and kidney transplant outcome
    Goldfarb-Rumyantzev, A
    Hurdle, JF
    Scandling, J
    Wang, Z
    Baird, B
    Barenbaum, L
    Cheung, AK
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (01) : 167 - 175
  • [10] Immune Reconstitution Following Rabbit Antithymocyte Globulin
    Gurkan, S.
    Luan, Y.
    Dhillon, N.
    Allam, S. R.
    Montague, T.
    Bromberg, J. S.
    Ames, S.
    Lerner, S.
    Ebcioglu, Z.
    Nair, V.
    Dinavahi, R.
    Sehgal, V.
    Heeger, P.
    Schroppel, B.
    Murphy, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (09) : 2132 - 2141